Aprecia Pharmaceuticals and CMIC CMO announced both companies will collaborate to develop business opportunities in Japan for Aprecia's ZipDose® Technology. CMIC CMO's services will include identifying prospects in Japan, generating awareness and facilitating discussions of technology licensing agreements, research collaborations and distribution partnerships. Through this engagement Aprecia seeks to expand its 3DP products globally, and this agreement highlights the importance of Japan in its long term strategy.
Aprecia is the world's first and only commercial-stage manufacturer of three-dimensionally printed pharmaceuticals. Its first 3DP innovation, ZipDose® Technology, can accommodate a wide variety of active pharmaceutical ingredients and formulation technologies to create high value products with unique performance characteristics such as rapid disintegration to better meet the needs and solve the problems of patients, caregivers and medical staff across multiple therapeutic categories. Beyond ZipDose® Technology, the company is developing additional applications for its 3DP manufacturing platform as a means to provide breakthrough products in multiple dose forms.
CMIC Group is the first and largest clinical CRO in Japan. Upon years, CMIC Group also expanded to provide comprehensive services in drug formulation development, clinical to commercial GMP manufacturing, clinical site management, regulatory consulting and contract sales.
"Aprecia sees a tremendous opportunity to create value in the Japanese pharmaceutical market through our 3DP technology platform via product license, development, manufacturing, and distribution partnerships with Japanese pharma companies," said Tim Tracy, Chief Executive Officer of Aprecia. "Entry into the Japanese pharma market requires a comprehensive understanding of the industry, competitive landscape, consumer preferences, market challenges and opportunities, stakeholder relationships, business contacts, etc., etc. As the leading provider of comprehensive pharmaceutical services in Japan, CMIC CMO is uniquely qualified to provide Aprecia with an efficient and effective way to enter the market.”